New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 5158 | Morphine hydrochloride | Narcotic opioid analgesic |
| 5146 | Sulforhodamine 101 | Fluorescent dye; selective astrocyte marker |
| 5130 | CTCE 9908 | CXCR4 antagonist; antitumor |
| 5126 | iMDK | Potent suppressor of MDK expression; antitumor |
| 5074 | ANQ 11125 | Selective motilin receptor antagonist |
| 5041 | PAOPA | Dopamine D2 receptor allosteric modulator |
| 4976 | ML 289 | Selective negative allosteric modulator at mGlu3 |
| 4946 | AIM 100 | Selective Ack1 inhibitor |
| 4899 | ML 120B dihydrochloride | Novel IKK2-selective inhibitor |
| 4859 | ML 202 | Pyruvate kinase M2 activator |
| 4780 | VUF 11207 fumarate | Potent CXCR7 agonist |
| 4747 | TC-G 1006 | Potent and selective sphingosine-1-phosphate receptor 1 (S1P1) agonist |
| 4697 | A 331440 dihydrochloride | Selective H3 antagonist |
| 3322 | ZD 9379 | Brain penetrant NMDA antagonist, acts at glycine site |
| 5160 | Medetomidine hydrochloride | Potent, highly selective α2 agonist |
| 5143 | Ononetin | TRPM3 blocker |
| 5115 | OXA (17-33) | Potent and selective peptide OX1 antagonist |
| 5082 | LDN 212320 | Increases EAAT2 expression; neuroprotective |
| 4983 | ACT 335827 | Potent and selective OX1 antagonist |
| 4130 | KN 92 | Inactive analog of KN 93. K+ channel (Kv) blocker |